REGULUS THERAPEUTICS
Regulus Therapeutics Is a biopharmaceutical company leading the discovery of a new class of high-impact medicines based on microRNAs. The discovery of MicroRNA in humans is one of the most exciting scientific breakthroughs in the last decade. MicroRNAs are small RNA molecules, typically 20 to 25 nucleotides in length, that do not encode proteins but instead regulate gene expression. It was founded in 2007 and is headquartered in Carlsbad, California.
REGULUS THERAPEUTICS
Industry:
Biotechnology Genetics Health Care Therapeutics
Founded:
2007-09-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.regulusrx.com
Total Employee:
51+
Status:
Active
Contact:
858-202-6300
Email Addresses:
[email protected]
Total Funding:
361.4 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt WordPress Font Awesome Nginx Microsoft Exchange Online
Similar Organizations
Xilio Therapeutics
Xilio Therapeutics is a biopharmaceutical company focused on developing highly-potent, targeted immuno-oncology therapeutics.
Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
Ansun BioPharma
Ansun BioPharma is a clinical-stage biopharmaceutical company focused on the development of host-directed anti-viral.
Ascenta Therapeutics
Ascenta Therapeutics, a clinical-stage biopharmaceutical company, focuses on the discovery and development of new medicines to treat cancer.
Ayala Pharmaceuticals
Ayala Pharmaceuticals a clinical-stage biopharmaceutical company focused on developing and commercializing small molecule therapeutics.
Bellicum Pharmaceuticals
Bellicum Pharmaceuticals is a clinical-stage biopharmaceutical company that is driving the future of cellular immuno-oncology (IO).
BioTheryX
BioTheryX is a clinical-stage biopharmaceutical company that focuses on the development of therapies for hematological malignancies.
Brooklyn ImmunoTherapeutics
Brooklyn ImmunoTherapeutics is a clinical=stage biopharmaceutical company discovers and develops a novel cytokine-based therapy.
Cascadian Therapeutics
Cascadian Therapeutics is a bio-pharmaceutical company that researches, develops, and sells therapeutic products for treatment of cancer.
CohBar
CohBar is a clinical-stage biotechnology company that focuses on the research and development of mitochondria based therapeutics.
Crestone
Crestone is a clinical stage biopharmaceutical company focused on inventing and developing novel mechanism.
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
Eloxx
Eloxx Pharmaceuticals is a clinical-stage biopharmaceutical company developing novel RNA-modulating drug candidates.
Fulgent Therapeutics
Fulgent Therapeutics, LLC is a pharmaceutical company focusing on developing and commercializing innovative cancer therapeutics.
Gossamer Bio
Gossamer Bio is a biopharmaceutical company focused on the discovery and development of novel and differentiated therapeutic products.
Idun Pharmaceuticals
IDUN Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of human therapeutics to control
Kind Pharmaceutical
Kind Pharmaceutical is a clinical-stage biopharmaceutical company that focuses on the discovery and development of anemia drugs.
Liquidia Technologies
Liquidia Technologies is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics.
Monopar
Monopar Therapeutics is an emerging biopharmaceutical company focused on developing orphan oncology compounds.
Motif BioSciences
Motif BioSciences, a population genetics company, focuses on the genetic causes of major diseases using human genetic data from individuals.
Rafael Holdings
Rafael Holdings is a company focused on the development of novel cancer therapies.
Raptor Pharmaceuticals
Raptor is a NASDAQ-listed biopharmaceutical company with the mission to develop and commercialize life-altering therapeutics.
Renova Therapeutics
Renova Therapeutics is an industry leader in the emerging field of gene therapy, pursuing the development of treatments.
Seres Therapeutics
Seres Therapeutics is a microbiome therapeutics company.
Stemline Therapeutics
Stemline Therapeutics is a clinical stage biopharmaceutical company developing oncology compounds that target cancer stem cells.
StemTek Therapeutics
StemTek is a biopharmaceutical company focused on the research and development of drugs for cancer treatment.
Tetra Therapeutics
Tetra Therapeutics is a clinical stage biotechnology company developing a portfolio of therapeutic products.
Vanda Pharmaceuticals
Vanda is a global biopharmaceutical company focused on the development and commercialization of innovative therapies.
Vical
Vical researches and develops biopharmaceutical products based on its patented DNA delivery technologies.
Zymenex
Zymenex is a Scandinavian biopharmaceutical company focused on the development and commercialization of novel enzyme replacement therapies
Current Advisors List
Current Employees Featured
Stock Details
Investors List
New Enterprise Associates
New Enterprise Associates investment in Post-IPO Equity - Regulus Therapeutics
Federated Kaufmann Fund
Federated Kaufmann Fund investment in Post-IPO Equity - Regulus Therapeutics
New Enterprise Associates
New Enterprise Associates investment in Post-IPO Equity - Regulus Therapeutics
Oxford Finance LLC
Oxford Finance LLC investment in Post-IPO Debt - Regulus Therapeutics
Sanofi
Sanofi investment in Funding Round - Regulus Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2022-06-02 | Regulus Therapeutics Names VP |
| 2021-12-03 | Regulus Therapeutics Names VP |
Official Site Inspections
http://www.regulusrx.com
- Host name: 234.80.154.104.bc.googleusercontent.com
- IP address: 104.154.80.234
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
More informations about "Regulus Therapeutics"
Regulus Therapeutics
Oct 8, 2024 · We are laser-focused on our mission: to improve the lives of patients and their families. Our pipeline programs target kidney diseases of high unmet need, including ADPKD. …See details»
About - Regulus Therapeutics
Regulus aims to develop important, novel oligonucleotide therapeutics that are designed to inhibit dysregulated micro RNA targets for the benefit of patients with genetically based orphan diseases.See details»
Management - Regulus Therapeutics - ir.regulusrx.com
Senior Vice President and General Counsel. Denis Drygin, Ph.D. Chief Scientific OfficerSee details»
Regulus Therapeutics - Wikipedia
Regulus Therapeutics Inc. is a clinical stage biopharmaceutical company focused on the development of first-in-class drugs that target microRNAs to treat a broad range of diseases. Regulus was established in September 2007 by Alnylam Pharmaceuticals and Isis Pharmaceuticals. See details»
Overview - Regulus Therapeutics
Oct 8, 2024 · Regulus aims to develop novel oligonucleotide therapeutics that are designed to inhibit dysregulated microRNA targets for the benefit of patients with genetically based orphan diseases. Latest Quarter. Press Releases.See details»
Patients - Regulus Therapeutics
At Regulus, patients are at the heart of all our efforts. We work with patient advocacy organizations to enhances our ability to better understand our patients and their needs. …See details»
Board of Directors - Regulus Therapeutics
Chair of the board, has served on our board of directors since our conversion to a corporation in January 2009 and as our Chair since June 2013, and prior to that was a director of Regulus …See details»
Regulus Therapeutics - Crunchbase Company Profile & Funding
Regulus Therapeutics is a clinical stage biopharmaceutical company focused on the development and discovery of microRNA therapeutics. Regulus Therapeutics may be growing as evidenced …See details»
Regulus Therapeutics - LinkedIn
Regulus Therapeutics Inc. (Nasdaq:RGLS) is a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs.See details»
Corporate Governance - Regulus Therapeutics
Implicit in this philosophy is the importance of sound corporate governance. It is the duty of the Board of Directors to serve as a prudent fiduciary for shareholders and to oversee the …See details»
Regulus Therapeutics - VentureRadar
Website: http://www.regulusrx.com Develops novel oligonucleotide therapeutics targeting dysregulated microRNA for patients with genetically based orphan diseases, focusing on …See details»
Technology - Regulus Therapeutics
We believe that targeting pathways of human disease with antisense oligonucleotides targeting RNA biology represents a novel and potentially powerful therapeutic approach for multiple …See details»
Regulus Therapeutics Information - RocketReach
Regulus Therapeutics is a Biotechnology Research, Pharmaceuticals, and Biotechnology company located in San Diego, California with $10.1 million in revenue and 45 employees. …See details»
Regulus Therapeutics (USA) Funding: $480.9M - Medical Startups
Nov 7, 2024 · Website: http://regulusrx.com Regulus Therapeutics is a biopharmaceutical company involved in the R&D of high-impact medicines based on microRNAs.See details»
Regulus Reports Clinical Hold of RG-101 - NATAP
A live webcast of the call will be available online at www.regulusrx.com. To access the call, please dial (877) 257-8599 (domestic) or (970) 315-0459 (international) and refer to conference ID …See details»
Investor FAQs - Regulus Therapeutics
Regulus' investor relations department is happy to answer any shareholder questions. You may contact Regulus' investor relations by phone at 858-202-6300, or by email at [email protected]See details»
WuXi STA and Regulus Announce microRNA Development and …
Feb 21, 2018 · Regulus is advancing several programs in the renal, hepatic, and central nervous system diseases. Regulus maintains its corporate headquarters in La Jolla, CA. For more …See details»
Rekha Garg, M.D., M.S. – Regulus Therapeutics
Rehka joined Regulus in 2022 and is a physician executive with over 20 years of experience in leadership roles in the biopharma industry, across multiple therapeutic areas including kidney …See details»
Regulus Therapeutics Inc. - Cruelty Free Investing
Regulus Therapeutics, Inc. engages in the discovery and development of drugs targeting microRNAs. It is developing RG-101, which targets miR-122, a host factor for the hepatitis C …See details»
Principal Scientist/Associate Director, Chemistry
Regulus Therapeutics Inc. (Nasdaq: RGLS) is a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs.See details»